FDA Asks Sanofi to Pull Zantac From the Market, Citing Cancer Risk
Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…
Börse:
78,385€
-2,19%
Echtzeit-Aktienkurs SANOFI SA INHABER EO 2
Bid:
78,160€
Ask:
78,610€
Nachrichten zur SANOFI SA INHABER EO 2 Aktie
Heres Why Sanofi Is An Underappreciated Coronavirus Stock
The pharma company is making progress on its portfolio of coronavirus therapies and the execution of its new growth strategy....…
FDA Asks for Recalls of Sanofis Zantac and All Generic Versions
The agency says there is a risk that some of the heartburn pills may contain unacceptable levels of NDMA, a…
Sanofi: Information on Sanofis Shareholder General Meeting of Tuesday, April 28, 2020
Information on Sanofis Shareholders General Meeting of Tuesday, April 28, 2020...…
Sanofi buy
FRANKFURT (dpa-AFX Analyser) - Die Investmentbank Oddo BHF hat das Kursziel für Sanofi von 105 auf 91 Euro gesenkt, aber…
Translate Bio, Sanofi to Jointly Develop Coronavirus Vaccine
Translate Bio (TBIO) gains on collaboration with Sanofi for a mRNA vaccine development for COVID-19....…
Why Sanofis Stock Is Trading Higher Today
Sanofi (NYSE: SNY) shares are trading higher on Monday.
The company reported the first patient outside of the U.S. has been…
Regeneron, Sanofi Enroll First Person Outside of U.S. in Coronavirus Treatment Test
Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…
Stocks making the biggest moves in the premarket: J&J, Sanofi, Regeneron, La-Z-Boy, Apple & more
The stocks making the biggest moves in premarket trading include J&J, Sanofi, Regeneron, La-Z-Boy, Apple, and more....…
First patient treated in Regeneron, Sanofi trial for COVID-19 treatment
Regeneron Pharmaceuticals Inc. and Sanofi SA said Monday that the first patient in a global clinical trial testing…
Sanofi, Translate Bio to develop novel mRNA vaccine for COVID-19 disease
The latest deal is said to leverage an existing agreement between the two companies established in 2018 for the development…
Europa braucht Eigenständigkeit im Gesundheitsbereich
Sobald die Pandemie eingedämmt ist, müssen wir die Lehren daraus für unsere Zukunft ziehen. Die EU-Länder müssen in ihre Produktionskapazitäten…
Sanofi, Regeneron expand testing of potential coronavirus treatment
Sanofi and Regeneron
Pharmaceuticals Inc have expanded a clinical trial of
their rheumatoid arthritis drug Kevzara as a coronavirus
treatment to patients outside…
Sanofi: First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19
First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19...…
Sanofi CEO talks testing vaccine, existing drugs to combat coronavirus
Jim Cramer talks with Sanofi CEO Paul Hudson about the French drugmaker's efforts to combat the noel coronavirus and launch…
Sanofi CEO talks fast-tracking coronavirus vaccine development process
Sanofi CEO Paul Hudson explains how the French pharmaceutical giant seeks to cut the development of a coronavirus vaccine from…
Sanofi and Translate Bio Team Up to Work on a Coronavirus Vaccine
Translate Bios messenger RNA technology will make the development process faster than the traditional methods....…
European advisory group backs Sanofis isatuximab for multiple myeloma
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
The Daily Biotech Pulse: Sanofi-Translate Bio Join Hands For Coronavirus Vaccine, TherapeuticsMD Suspends Guidance
Heres a roundup of top developments in the biotech space over the last 24 hours.
None of the NYSE- or Nasdaq-listed…
Novartis, life sciences firms collaborate with BMGF to fight against COVID-19 disease
Novartis, Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, Eli Lilly, Gilead, GSK, Johnson & Johnson, Merck, Pfizer, Sanofi, BD and bioMérieux are…
Sanofi, Translate Bio team virus vaccine candidate
The French pharmaceutical major Sanofi SA said Friday that it is collaborating with Translate Bio Inc. to develop a new…
Sanofi and U.S. group Translate Bio to work on COVID-19 vaccine
French healthcare company Sanofi
Pasteur and U.S. company Translate Bio
announced on Friday plans to collaborate on developing a vaccine
to treat the…
Sanofi receives positive CHMP opinion for Sarclisa® (isatuximab) for the treatment of relapsed and refractory multiple myeloma
Sanofi receives positive CHMP opinion for Sarclisa® (isatuximab) for the treatment of relapsed and refractory multiple myeloma...…
Sanofi and Translate Bio collaborate to develop novel mRNA vaccine candidate against COVID-19
Sanofi and Translate Bio collaborate to develop novel mRNA vaccine candidate against COVID-19...…
Sanofi Pasteur and Translate Bio to Collaborate to Develop a Novel mRNA Vaccine Candidate Against COVID-19
The two companies will jointly investigate multiple candidates with the goal of advancing an efficacious and safe SARS-CoV-2 vaccine into…
Sanofi: information concerning the total number of voting rights and shares, February 2020
...…
The Zacks Analyst Blog Highlights: Gilead Sciences, Regeneron, Sanofi, Moderna and Inovio Pharmaceuticals
The Zacks Analyst Blog Highlights: Gilead Sciences, Regeneron, Sanofi, Moderna and Inovio Pharmaceuticals...…
Sanofi successfully prices EUR 1.5 billion of bond issue
Sanofi successfully prices EUR 1.5 billion of bond issue...…
The Zacks Analyst Blog Highlights: Pfizer, Roche, Sanofi, Lilly and Merck
The Zacks Analyst Blog Highlights: Pfizer, Roche, Sanofi, Lilly and Merck...…
Feinstein Institutes begins three clinical trials for COVID-19 patients
Feinstein Institutes researchers have collaborated with Gilead Sciences, Regeneron Pharmaceuticals and Sanofi to detect efficient treatments for patients currently hospitalised…
Why Sanofis Coronavirus Vaccine Work Hasnt Helped Its Stock
While investors reward other biotech stocks for coronavirus work, Sanofi shares are in the doldrums....…
Nonprofit Group Starts Multiple COVID-19 Clinical Studies
Potential coronavirus treatments from Regeneron, Sanofi, and Gilead Sciences will get more chances to prove themselves effective....…
Bristol-Myers Squibb , Sanofi strike out in bid to stop Plavix litigation
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
VIRUS: Produktionsengpässe bei Corona-Tests
GENF (dpa-AFX) - Die zur Zeit vorhandene Zahl der Coronavirus-Tests reicht nach Angaben der Pharmaindustrie nicht…
The Zacks Analyst Blog Highlights: UnitedHealth, Sanofi, United Parcel Service, Caterpillar and Activision Blizzard
The Zacks Analyst Blog Highlights: UnitedHealth, Sanofi, United Parcel Service, Caterpillar and Activision Blizzard...…
Sanofi buy
NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für Sanofi nach Studiendaten zum Pfizer-Medikament Abrocitinib auf…
Sanofi Outperform
NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Sanofi auf "Outperform" mit einem Kursziel von…
Regeneron/Sanofi to Test Kevzara for Severe Coronavirus Infection
A U.S. based phase II/III study has been initiated to evaluate Regeneron (REGN)/Sanofis (SNY) rheumatoid arthritis drug Kevzara to treat…
Sanofi Gets In-House Developed Cancer Drug Sarclisa To The Finish Line With FDA Approval
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Sanofi Equal weight
LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat Sanofi von "Underweight" auf "Equal Weight" hochgestuft, das Kursziel aber von…
Wettlauf mit Risiken - Auf der Suche nach dem Corona-Impfstoff
- von Julie Steenhuysen und Patricia Weiss
Frankfurt (Reuters) - In der Corona-Krise nimmt das Ringen um die Hersteller von potenziellen…
ANALYSE-FLASH: Barclays hebt Sanofi auf Equal Weight - Ziel gesenkt
LONDON (dpa-AFX Broker) - Die britische Investmentbank Barclays hat Sanofi von "Underweight" auf "Equal Weight" hochgestuft, das Kursziel aber von…
ANALYSE-FLASH: Barclays hebt Sanofi auf 'Equal Weight' - Ziel gesenkt
LONDON (dpa-AFX Broker) - Die britische Investmentbank Barclays hat Sanofi von "Underweight" auf "Equal Weight"…
Regeneron und Sanofi testen Wirkstoff gegen Covid-19 klinisch
Von Matt Grossman NEW YORK (Dow Jones)--Die Pharmakonzerne Regeneron und Sanofi testen ein zugelassenes Medikament zur Behandlung von rheumatischen…
Regeneron and Sanofi launch Kevzara clinical program for COVID-19
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Regeneron Launches US Trials for Coronavirus Treatment With Frances Sanofi
Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…
Regeneron and Sanofi Begin Global Kevzara® (sarilumab) Clinical Trial Program in Patients with Severe COVID-19
TARRYTOWN, N.Y. and CAMBRIDGE, Mass. , March 16, 2020 /PRNewswire/…
Sanofi, Regeneron begin testing arthritis drug as coronavirus treatment
Sanofi SA and partner
Regeneron Pharmaceuticals Inc have started a clinical
trial of their rheumatoid arthritis drug Kevzara as a treatment
for the…
ROUNDUP: Stada peilt starkes Wachstum an - Russland im Fokus
FRANKFURT (dpa-AFX) - Stada will nach einem starken Geschäftsjahr die Position auf dem europäischen Arznei-Markt…
Heres Why The Coronavirus Epidemic Could Boost Sanofis Spinoff
As the coronavirus outbreak sparks fears of drug shortages, Sanofi offers a solution....…